Masahiro Abe

7.2k total citations
217 papers, 5.1k citations indexed

About

Masahiro Abe is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Masahiro Abe has authored 217 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 82 papers in Hematology and 80 papers in Oncology. Recurrent topics in Masahiro Abe's work include Multiple Myeloma Research and Treatments (74 papers), Bone health and treatments (37 papers) and Peptidase Inhibition and Analysis (32 papers). Masahiro Abe is often cited by papers focused on Multiple Myeloma Research and Treatments (74 papers), Bone health and treatments (37 papers) and Peptidase Inhibition and Analysis (32 papers). Masahiro Abe collaborates with scholars based in Japan, United States and United Kingdom. Masahiro Abe's co-authors include Toshio Matsumoto, Shuji Ozaki, Hirokazu Miki, Toshihiro Hashimoto, Shinsuke Kido, Michihiro Nakamura, Kunio Hiwada, Kazunori Ishimura, Koichiro Hayashi and Keiji Moriyama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Masahiro Abe

202 papers receiving 5.0k citations

Peers

Countries citing papers authored by Masahiro Abe

Since Specialization

Citations

This map shows the geographic impact of Masahiro Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Abe more than expected).

Fields of papers citing papers by Masahiro Abe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Abe. The network helps show where Masahiro Abe may publish in the future.

Co-authorship network of co-authors of Masahiro Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Abe. A scholar is included among the top collaborators of Masahiro Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Abe. Masahiro Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imaging in plasma cell disorders—consensus recommendations of the Asian myeloma network bone imaging workgroup 2025 ·The Lancet Regional Health - Western Pacific ·Chandramouli Nagarajan, (unknown), (unknown), (unknown), (unknown), (unknown), Gin Gin Gan, (unknown), Chor Sang Chim, (unknown), Wenming Chen, Kihyun Kım, S. Vincent Rajkumar, Brian G.M. Durie, Wee Joo Chng, Masahiro Abe	0
2	Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study 2024 ·Allergology International ·Maho Suzukawa, Ken Ohta, M. Sugimoto, Nobuharu Ohshima, Nobuyuki Kobayashi, Hiroyuki Tashimo, Yasushi Tanimoto, (unknown), Goro Kimura, Shohei Takata, Takako Nakano, Takafumi Yamashita, Satoshi Ikegame, (unknown), Masahiro Abe, (unknown), Yosuke Kamide, Kazunori Sasaki, Hiroya Hashimoto	2
3	Effective Intractable Chylous Ascites Treatment by Lymphangiography with Lipiodol in a Patient with Follicular Lymphoma 2024 ·Internal Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Kimiko Sogabe, (unknown), Takeshi Harada, Shiro Fujii, (unknown), Masahiro Abe, (unknown)	1
4	Acute myeloid leukemia developed through myeloproliferative features during immunosuppressive therapy for juvenile idiopathic arthritis 2024 ·The Journal of Medical Investigation ·(unknown), (unknown), (unknown), (unknown), (unknown), Takeshi Harada, Shiro Fujii, Hirokazu Miki, (unknown), (unknown), (unknown), Masahiro Abe, Shingen Nakamura	0
5	Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study 2024 ·BMJ Supportive & Palliative Care ·(unknown), Shoichiro Takao, (unknown), (unknown), Michiko Yamashita, (unknown), (unknown), Kimiko Sogabe, (unknown), Shiro Fujii, Takeshi Harada, Hirokazu Miki, Masahiro Abe, Shingen Nakamura	0
6	Raman microspectroscopy for label‐free diagnosis of amyloid light‐chain amyloidosis in various organs 2024 ·Journal of Raman Spectroscopy ·Shin‐ichiro Yanagiya, Takeshi Honda, Hiroki Takanari, Kimiko Sogabe, Shingen Nakamura, Yoshimi Bando, Koichi Tsuneyama, Masahiro Abe, Hirokazu Miki	2
7	Elotuzumab‐mediated ADCC with Th1‐like Vγ9Vδ2 T cells to disrupt myeloma–osteoclast interaction 2024 ·Cancer Science ·Yusuke Inoue, (unknown), Jumpei Teramachi, (unknown), Asuka Oda, (unknown), (unknown), Kimiko Sogabe, (unknown), (unknown), Shiro Fujii, Shingen Nakamura, Hirokazu Miki, (unknown), Itsuro Endo, Kumiko Kagawa, Shuji Ozaki, Masahiro Hiasa, Takeshi Harada, Masahiro Abe	1
8	VDR is an essential regulator of hair follicle regression through the progression of cell death 2023 ·Life Science Alliance ·(unknown), Yoko Yamamoto, Shigeaki Kato, Tatsuya Takemoto, Masahiro Abe, Toshio Matsumoto, Seiji Fukumoto, Shun Sawatsubashi	8
9	Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes 2023 ·Heliyon ·(unknown), Shingen Nakamura, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kiyoe Kurahashi, (unknown), Takeshi Harada, Akio Kuroda, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe, Ken‐ichi Aihara	14
10	A machine learning model using SNPs obtained from a genome-wide association study predicts the onset of vincristine-induced peripheral neuropathy 2022 ·The Pharmacogenomics Journal ·Hiroki Yamada, (unknown), Naoto Okada, Shingen Nakamura, Kumiko Kagawa, Shiro Fujii, Hirokazu Miki, Keisuke Ishizawa, Masahiro Abe, Youichi Sato	1
11	Rituximab therapy for intractable pemphigus: A multicenter, open‐label, single‐arm, prospective study of 20 Japanese patients 2022 ·The Journal of Dermatology ·Jun Yamagami, (unknown), Takeru Funakoshi, (unknown), Ryo Tanaka, Hayato Takahashi, Hideyuki Ujiie, Hiroaki Iwata, Yoji Hirai, Keiji Iwatsuki, Norito Ishii, (unknown), Takayuki Abe, Ryo Takemura, (unknown), Masahiro Abe, Masayuki Amagai	4
12	Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes 2021 ·Journal of Diabetes Investigation ·(unknown), (unknown), (unknown), (unknown), (unknown), Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Yasumasa Ikeda, Itsuro Endo, (unknown), Katsuhiko Yoshimoto, Akira Kondo, Toshiaki Tamaki, Toshio Matsumoto, Munehide Matsuhisa, Masahiro Abe, Ken‐ichi Aihara	5
13	Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span 2021 ·Biochemistry and Biophysics Reports ·Yuichi Takashi, Shun Sawatsubashi, Itsuro Endo, (unknown), Masahiro Abe, Munehide Matsuhisa, Daiji Kawanami, Toshio Matsumoto, Seiji Fukumoto	17
14	Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index 2021 ·Journal of Diabetes Investigation ·(unknown), Akio Kuroda, (unknown), Hiroyasu Mori, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Yuko Akehi, Ken‐ichi Aihara, Itsuro Endo, Masahiro Abe, Munehide Matsuhisa	5
15	[Mechanisms of myeloma-induced bone disease]. 2016 ·PubMed ·Masahiro Abe	2
16	[Myeloma bone disease]. 2014 ·PubMed ·Masahiro Abe	3
17	Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors 2013 ·PLoS ONE ·Takeshi Harada, Shuji Ozaki, Asuka Oda, Daisuke Tsuji, (unknown), (unknown), (unknown), Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Yoshiaki Kuroda, Shigeto Kawai, Kohji Itoh, Hisafumi Yamada‐Okabe, Toshio Matsumoto, Masahiro Abe	13
18	Suitability of commercial colloids for magnetic hyperthermia (vol 321, pg 1509, 2009) 2009 ·UCL Discovery (University College London) ·Mathew Kallumadil, Masaru Tada, Toshio Nakagawa, Masahiro Abe, Paul Southern, (unknown)	4
19	[Link between osteoclastogenesis, angiogenesis and myeloma expansion]. 2008 ·PubMed ·Masahiro Abe	4
20	Pay Structures and the Transformation of Japanese Firms―An Empirical Analysis of Performance and Pay Using Personnel Data― 2003 ·Econometric Reviews ·(unknown), Masahiro Abe, Katsuyuki Kubo	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact